Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Latest news

3/25/2022 Pharmaceutical Drug Production in Russia (February 2022)

In January–February 2022, Russian manufacturers produced RUB 118.3 billion worth of pharmaceutical drugs (manufacturer’s prices, VAT included), up 16.7% from January–February 2021. The result is quite comparable to that in the same period in 2021, when the growth rate in monetary terms was 16.9%. However, the growth rates in early 2022 were far from even, with 3.8% in January and 27.8% in February.

3/23/2022 Vaccine Export from Russia in 2021

The export of pharmaceutical drugs from Russia in 2021 reached a new all-time high in both volume and growth rates. Most of the exported drugs were vaccines, a total of RUB 78.4 billion (customs duties included, EEU countries excluded). The export volume in monetary terms (rubles) increased almost 21 times compared to 2020, with the COVID vaccines contributing to the growth rates the most, as expected.

3/18/2022 Customs Duties on the Import of Pharmaceutical Drugs and APIs to Russia in 2021

One of the anti-crisis measures prepared by the Government of the Russian Federation is the possibility to exempt from customs duties a number of “vital goods” imported into Russia, which may include pharmaceutical drugs and APIs. Customs duties, as part of the customs clearance procedure, are the main expense item of foreign economic activity participants. In 2021, for example, the importers of ready-made drugs paid RUB 18.5 billion in total.

3/10/2022 Import of Veterinary Drugs and Feed Supplements to Russia in 2021

In 2021, Russia imported RUB 36.7 billion worth of veterinary drugs (customs clearance and VAT included), up 7.2% from 2020, hardly comparable to that in 2019. As for feed supplements, the import volume was RUB 41.9 billion, and the growth rate was 4.3%.

3/9/2022 2021 Ranking of Pharmacy Chains in Russia

Pharmaceutical Retail Expected to Deal with Rush Demand and New Consumer Preferences in the Upcoming Months

All news [303]

Our competences

RNC Pharma is focused on providing information about development trends of Russian pharmaceutical market infrastructure component. Our experts also provide services on strategic marketing, such as forecasting, business planning, etc.